Jazz Pharmaceuticals
JAZZ
JAZZ
435 hedge funds and large institutions have $8.72B invested in Jazz Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 81 funds opening new positions, 131 increasing their positions, 172 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
435
Holders Change
+47
Holders Change %
+12.11%
% of All Funds
7.72%
Holding in Top 10
8
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+33.33%
% of All Funds
0.14%
New
81
Increased
131
Reduced
172
Closed
31
Calls
$115M
Puts
$78.8M
Net Calls
+$36M
Net Calls Change
+$23.5M
Top Buyers
| 1 |
BlackRock
New York
|
+$49.5M |
| 2 |
KBC Group
Brussels,
Belgium
|
+$41.5M |
| 3 |
Goldman Sachs
New York
|
+$38.9M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$35.7M |
| 5 |
Jennison Associates
New York
|
+$33.2M |
Top Sellers
| 1 |
Nuveen Asset Management
Chicago,
Illinois
|
-$87.5M |
| 2 |
DKCM
Davidson Kempner Capital Management
New York
|
-$74.5M |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
-$47.5M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$46.5M |
| 5 |
Renaissance Technologies
New York
|
-$38.9M |
